Effects of Enriched Gardens in Nursing Home Residents With Dementia
Launched by RIVAGES · May 21, 2021
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
The cluster controlled trial is conducted over a six months period after recruitment of residents from 4 different nursing homes in France. The participants are distributed into 3 groups. One group does not receive incentive from carers to visit any garden, the second group receives incentives to visit regularly a conventional sensory garden and the third group receive incentives from carers to visit regularly an enriched garden. The study is conducted over a period of 6 months. All participants are giving consent to the study. They will be evaluated before and after over 4 different tests....
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Give consent
- • Ability walking alone
- • Alzheimer's disease
- Exclusion Criteria:
- • No dementia
- • Severe dementia
- • Severe behavioural disorder
- • Inability to walk alone
About Rivages
Rivages is a leading clinical trial sponsor dedicated to advancing medical research and innovation. Specializing in the development and management of clinical studies across various therapeutic areas, Rivages combines scientific expertise with a commitment to ethical standards and regulatory compliance. The organization collaborates with healthcare professionals, research institutions, and pharmaceutical companies to facilitate the successful execution of clinical trials, ensuring the highest quality of data and patient safety. With a focus on fostering partnerships and leveraging cutting-edge technologies, Rivages aims to accelerate the delivery of new therapies to patients in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ivry Sur Seine, Val De Marne, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials